People

Paul M. Young and Daniela Traini have moved from the Pharmacy Faculty at the University of Sydney to the Woolcock Institute of Medical Research (WIMR) in order to establish a new Respiratory Technology team at the Institute. According to Young and Traini, "The WIMR is a world leading respiratory and sleep research organization whose aim is to foster, develop and … [Read more...] about Paul Young and Daniela Traini head up new Respiratory Technology Group

Prosonix has announced that Ken Cunningham will replace Jim Philips as Non-executive Chairman. Cunningham, who is also Chair of the company's scientific advisory board, is a former CEO of Skyepharma. He has been a member of the board of Prosonix since September 2011. Phillips, who is retiring from the board of directors, said, “After five years chairing Prosonix … [Read more...] about Ken Cunningham new Non-executive Chairman of Prosonix

OINDP component manufacturer Presspart has announced the appointment of Ameet Sule as Director of its new Inhalation Product Technology Centre (IPTC) in Blackburn, UK. Sule, who was most recently Director of Pulmonary Research at Lupin, will head the IPTC beginning January 15, 2013. He has almost 20 years of experience with respiratory delivery devices, formulations, … [Read more...] about Presspart hires Ameet Sule to head its Inhalation Product Technology Centre

Aptar Pharma has announced the appointment of Jean-Marc Pardonge as President of Aptar Pharma’s Prescription Division, succeeding Salim Haffar, and as General Manager of Aptar Stelmi. Aptar's prescription division develops and manufactures a range of nasal and pulmonary delivery devices. Pardonge has worked in the prescription division since 2000, first as R&D … [Read more...] about Aptar Pharma appoints Jean-Marc Pardonge President of prescription division

NanoBio Corporation, which is developing a several intranasal vaccines, has announced that David Peralta will succeed James R. Baker as the company's Chief Executive Officer after Baker was hired by Merck as Senior VP, Head Global Vaccine Franchise. In 2011, NanoBio announced a collaboration with Merck on an intranasal RSV vaccine. Peralta has worked for NanoBio since … [Read more...] about NanoBio promotes David Peralta to CEO

Lightlake Therapeutics, which is developing naloxone nasal sprays for several eating disorders, has announced the appointment of former FDA Commissioner David Kessler as a strategic advisor. Kessler is the author of The End of Overeating: Taking Control of the Insatiable American Appetite. Lightlake CEO Roger Crystal commented, "We are very pleased to add Dr. … [Read more...] about Lightlake appoints former FDA commissioner as advisor